Vimarsana
Biggest News Aggregation in the World

Page 2 - N4 Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from N4 Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In N4 Pharma Today - Breaking & Trending Today

N4 Pharma (LON:N4P) Sets New 1-Year Low at $1.40 - Vimarsana News

N4 Pharma (LON:N4P) Sets New 1-Year Low at $1.40

Shares of N4 Pharma Plc (LON:N4P – Get Free Report) hit a new 52-week low on Tuesday . The company traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.57 ($0.02), with a volume of 6851 shares trading hands. The stock had previously closed at GBX 1.55 ($0.02). N4 Pharma Stock Up […]

N4 Pharma (LON:N4P) Hits New 12-Month Low at $1.50 - Vimarsana News

N4 Pharma (LON:N4P) Hits New 12-Month Low at $1.50

N4 Pharma Plc (LON:N4P – Free Report) shares hit a new 52-week low during trading on Friday . The stock traded as low as GBX 1.50 ($0.02) and last traded at GBX 1.64 ($0.02), with a volume of 214540 shares. The stock had previously closed at GBX 1.60 ($0.02). N4 Pharma Stock Performance The company […]

Source: wkrb13.com
N4 Pharma (LON:N4P) Reaches New 12-Month Low at $1.50 - Vimarsana News

N4 Pharma (LON:N4P) Reaches New 12-Month Low at $1.50

N4 Pharma Plc (LON:N4P – Free Report)’s share price reached a new 52-week low on Friday . The stock traded as low as GBX 1.50 ($0.02) and last traded at GBX 1.64 ($0.02), with a volume of 214540 shares. The stock had previously closed at GBX 1.60 ($0.02). N4 Pharma Price Performance The firm has […]

N4 Pharma (LON:N4P) Stock Price Up 10.5% - Vimarsana News

N4 Pharma (LON:N4P) Stock Price Up 10.5%

N4 Pharma Plc (LON:N4P – Get Rating)’s share price traded up 10.5% on Tuesday . The company traded as high as GBX 2.29 ($0.03) and last traded at GBX 2.10 ($0.03). 5,110,068 shares were traded during trading, an increase of 697% from the average session volume of 641,109 shares. The stock had previously closed at […]